(Q37012089)

17 August 2017

1 reference

title

Epitope-based vaccine against influenza (English)

1 reference

17 August 2017

1 reference

2

Ruth Arnon

1 reference

17 August 2017

Tamar Ben-Yedidia

1

1 reference

17 August 2017

1 December 2007

1 reference

Expert Review of Vaccines

17 August 2017

1 reference

17 August 2017

6

1 reference

17 August 2017

6

1 reference

17 August 2017

939-948

1 reference

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

17 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Improved design and intranasal delivery of an M2e-based human influenza A vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Design of peptide and polypeptide vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Peptide vaccines against hepatitis B virus: from animal model to human studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Towards an epitope-based human vaccine for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

A synthetic vaccine against influenza with built-in adjuvanticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Molecular mechanisms of variation in influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Ab and T cell epitopes of influenza A virus, knowledge and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Synthetic peptides as vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Rational design of Salmonella-based vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Immune responses to epitopes inserted in Salmonella flagellin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Nonclassical HLA-G molecules are classical peptide presenters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.6.939

21 January 2018

Identifiers

DOI

10.1586/14760584.6.6.939

1 reference

17 August 2017

1 reference

PubMed ID

18034655